Lorne Cancer 25th Lorne Cancer Conference 2013
Poster Session 1
7:30PM - 10:00PM
Thursday, 14th February
Exhibition Hall
- Targeting glucose metabolism - a strategy for overcoming drug resistance in breast cancer - Santhi Achuthan
- Coordinate methylation of the alkaline phosphatase gene family in colon cancer. Implications for understanding the manifestation of the CpG island methylator phenotype (CIMP) - Sheren J Al-Obaidi
- Investigating the function of the novel nuclear protein Manp. - James Allen
- Evaluation the Biological activity of a computationally de novo deign Peptide in Skin Cancer Cells in vitro - Nahlah Almansour
- Lmo2 induced precancerous stem cells (pre-CSCs) require Notch and IL-7 signalling pathways for survival. - Raed F Alserihi
- UNCOUPLING THE p53-DEPENDENT AND INDEPENDENT CELL CYCLE CHECKPOINTS UPON INHIBITION OF POL I TRANSCRIPTION - Marcia Amalia
- Cytotoxic effects of pineapple bromelain in gastrointestinal carcinoma cell lines - Afshin Amini
- SR protein splicing factors regulate stem cell properties - Minna-Liisa Anko
- Impact of overexpression of pro-survival proteins on the development and treatment of MLL-AF9 acute myeloid leukaemia - Natasha Anstee
- Cancer Drug Discovery: ACRF Drug Discovery Centre for Childhood Cancer - Greg M Arndt
- New implication for an old drug: minocycline as a potential candidate for the treatment of ovarian cancer-induced malignant ascites - Parvin Ataie Kachoie
- The expression of Dicer and Drosha in lymph node metastases of triple negative breast cancer. - Kelly A Avery-Kiejda
- Monepantel suppress ovarian cancer cell proliferation by arresting cell cycle at G1 and down regulating cycline A and E, Cdk 2 and 4 - Farnaz Bahrami B.
- Cyclin-dependent kinase inhibitor Dinaciclib (SCH 727965) induces apoptosis of MLL-AF9 murine tumour cells - Adele J Baker
- Potential markers for metformin susceptibility in colorectal cancer - Alice C Barnett
- Heterogeneity and plasticity in melanoma leads to treatment failure and increased invasiveness that can be blocked by targeting TSP-1 and/or SNAIL - Andreas Behren
- The Transcription Factor Runx2 is Important for Luminal Differentiation in the Pregnant Mammary Gland - Sarah Best
- An Exploration of the 11q13 Breast Cancer Susceptibility Locus Using 3C and 4C Chromatin Conformation Capture Technologies - Joshua Betts
- Developing Polyomic Personalised Therapeutic Strategies for Pancreatic Cancer: Molecular Phenotyping for Treating “One Patient at a Time”. - Andrew V Biankin
- Noxa and Puma are the main drivers of chemotherapy related apoptosis in MLL-AF9 AML - Rebecca A Bilardi
- microRNA-223 TARGETS STATHMIN AND REGULATES CELL MIGRATION IN MALIGNANT MESOTHELIOMA - Kimberly A Birnie
- Delineating the tumor suppressive role of Scribble in prostate cancer metastasis - Yvonne C Borsetti
- Investigating the effect of assay variation in determining whether melanoma follows a CD271-based cancer stem cell model. - Samantha E Boyle
- Deregulated gp130/Stat3-Driven inflammation in lung cancer development - Gavin Brooks
- The Transcriptome of Glioblastoma Stem Cells. - Daniel V Brown
- Recruitment of human telomerase to telomeres - Tracy M Bryan
- The contribution of stromal caveolin-1 to breast cancer metastasis. - Allan D Burrows
- Continuous Treatment With Low Concentrations of the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma Cells - Jason Cain
- Hedgehog Signaling Maintains a Primitive Osteoblast Phenotype in Osteosarcoma - Jason Cain
- Designing molecular biomarkers of therapeutic response to CX-5461, a first-in-class RNA Polymerase I inhibitor, for an upcoming Phase I clinical trial - Don P Cameron
- The p53 isoform, Δ133p53 binds to and inhibits the p53 family members, p63 and p73. - Hamish G Campbell
- SLIRP, a nuclear receptor corepressor, is a tumor suppressor in CRC that regulates cross-talk between the retinoic acid and notch signaling pathways - Patrick A Candy
- Genome wide RNAi screen to identify regulators of the oncoprotein LMO4 - Bianca D Capaldo
- The FAcilitates Chromatin Transcription (FACT) protein complex promotes neuroblastoma tumour initiation - Daniel R Carter
- Mechanisms underlying prostate cancer cell death induced by combinatorial treatment with an HDAC inhibitor and an antiandrogen - Sarah Carter
- Increasing intracellular bioavailable copper destroys prostate cancer - Michael A Cater
- An in vitro model of breast cancer dormancy for use in therapy discovery - Anannya Chakrabarti
- Defining the involvement of the E6AP-PML axis in human prostate cancer. - Ai-Leen Chan
- LRH-1 regulates hnRNPA1 and A2/B1 expression to modulate proliferation in breast cancer cells - Ashwini Chand
- Tumour immune infiltrate links tumour metastatic behavior and systemic Neutrophil-Lymphocyte Ratio (NLR) in colorectal cancer patients - Kellie A Charles
- DNA methylation patterns in pediatric Acute Lymphoblastic Leukemia - Zac Chatterton
- THE UBIQUITIN LIGASE SIAH IS A NOVEL REGULATOR OF EPITHELIAL-MESENCHYMAL TRANSITION IN BREAST CANCER - Anna Chen
- HIGH TRIM16 EXPRESSION PREDICTS FAVOURABLE OUTCOME IN PATIENTS WITH METASTATIC MELANOMA - Belamy Cheung
- INCREASING THE EFFECTIVENESS OF RETINOID ANTICANCER THERAPY FOR NEUROBLASTOMA - Belamy Cheung
- Diagnostic Serum Biomarkers for Canine Hemangiosarcoma: a Potential Model of Human Angiosarcoma - Eunju Choi
- Apoptotic sensitivity of tumour cells to HDACi is determined by sustained induction of the immediate-early genes Jun and Atf3. - Anderly C Chueh
- Characterisation of a novel regulator of Hedgehog signalling, which regulates medulloblastoma tumour growth. - Sarah E Conduit
- Differentiation and function of Foxp3+effector regulatory T cells. - Erika Cretney
- Deletion of Myb in keratin 14 expressing cells delays mammary cancer onset - Ryan Cross
- Whole exome sequence analysis of an in vitro model of drug-resistant T-cell acute lymphoblastic leukaemia - Mark N Cruickshank
- Parity (childbearing) reduces the numbers of the MaSC-enriched CD24+CD49fhi cells. - Genevieve Dall
- Oncogenic properties of cAMP Response Element Binding (CREB) protein in brain tumour cells - Paul Daniel
- Functional analysis of genes in regions commonly amplified in high-grade serous and endometrioid ovarian cancer - Sally J Davis
- A novel DNA damage-induced apoptotic pathway cooperates with p53 to enforce tumour suppression - Alex RD Delbridge
- Determining the Role of Tropomyosins in Actin-Mediated Apoptosis - Melissa Desouza
- Cooperative killing of MYC-driven B-lymphoma cells by inhibitors of the PI3K/AKT/mTOR pathway and RNA Polymerase I transcription - Jennifer R Devlin
- Characterisation of pro-invasive transcriptional programs regulated by the Fra-1 transcription factor - Jeannine Diesch
- Reduced expression of HDAC3 contributes to the resistance against HDAC inhibitor, vorinostat (SAHA) in mature lymphoid malignancies - Jianmin (Diane) Ding
- Mast Cells and Macrophages are Therapeutic Targets in Inflammation-Associated Gastric Cancer - Moritz Eissmann
- HoxA9-mediated immortalisation of myeloid progenitors requires Bcl-2 - Gabriela Brumatti
- Osteogenic differentiation of mesenchymal stem cells by PEDF in alginate microbeads - Mina Elahy
- A novel murine model of lung cancer that facilitates acceleration of K-RasG12D driven tumourigensis - Imogen Elsum
- TRAF2 regulates TNF related inflammation and cell death in keratinocytes. - Nima Etemadi
- Development of Arginine Methyltransferase PRMT5 Inhibitors as Novel Agents for the Treatment of Cancers - Hendrik Falk
- A Genome-wide screen for novel genes involved in sensitisation to Histone Deacetylase inhibitors - Katrina J Falkenberg
- MDM4 IS A NOVEL THERAPEUTIC TARGET IN HUMAN MELANOMA - Clare Fedele
- Differential effects of MUC1 expression in colon cancer cells. - Harvey R Fernandez
- Inhibition of histone acetyltransferases contributes to the anti-cancer activity of the phenothiazines - Harvey R Fernandez
- Glucocorticoids inhibit breast tumour cell migration but increase metastasis to the lung in a mouse model of breast cancer - Ebony R Fietz
- Understanding stathmin’s role in neuroblastoma metastasis - Christopher Fife
- Differential microRNA expression following transformation of embryonic liver progenitor cells as a model for the development of hepatocellular carcinoma - Megan Finch
- Investigating the roles of Epstein-Barr virus in the pathogenesis of Burkitt lymphoma - Leah Fitzsimmons
- Screening for neuroblastoma drugs selectively active in the bone marrow environment - Jamie I Fletcher
- The pro-tumourigenic role of microglia in glioblastoma multiforme pathogenesis: influence of CypA and CD147 signalling. - Gurkiran Kaur Flora
- Molecular profiling of Pheochromocytoma - Aidan Flynn
- Imaging Beyond the Diffraction Limit - Peter Franklin
- Determinants of acquired chemo-resistance in ovarian cancer - Sarah Ftouni
- ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer - David Gallego Ortega
- Expression of each gene of the polyamine pathway is prognostic of outcome and is directly regulated by the MYCN oncogene in neuroblastoma - Laura Gamble
- E6AP as a novel regulator of the ASPP family members - Cristina Gamell
- Sensitivity to dichloroacetate is determined by PDK expression - Bevan P Gang
- Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation - Orla M Gannon
- A PR55α-containing PP2A complex positively regulates Fra-1/c-Jun function in tumour cells - Omer Gilan
- Axl drives the development of acquired resistance to tyrosine kinase inhibitor therapy in head and neck cancer - Keith M Giles
- Role of pro‐survival BCL-2 family members in haematopoiesis and acute myeloid leukemia. - Stefan P Glaser
- Co-Culturing Prostate Cancer Cells with Bone Stromal Cells:A Reciprocal Interaction - Tristan T Glover
- The asymmetric cell division regulator GPSM2 controls mammary progenitor activity and breast cancer progression. - Nathan J Godde
- Phylogenetic analysis of clonal evolution of acquired drug resistance in liposarcoma - David Goode
- Mitochondrial-STAT3 supports K-Ras induced myeloproliferative disease in vivo. - Daniel J Gough
- Mitochondrial-STAT3 dependent regulation of glutathione synthesis is a tumour specific vulnerability. - Daniel Gough
- - Stephanie Grabow
- Mcl-1 sustains survival of Myc over-expressing pre-leukaemic B lymphoid cells in Eμ-myc transgenic mice - Stephanie Grabow
- Glioblastoma-specific Domain IV mutations in the EGFR are able to covalently dimerise in response to ligand and the small molecule inhibitors gefitinib and erlotinib. - Sameer A Greenall
- A double strike against leukaemia: Dual targeting of PI3K and Cdk9 rapidly and selectively induces apoptosis in human AML cells. - Mark Guthridge
- Targeted deletion of ILK in tumour-initiating cells improves survival of mice with highly aggressive Hedgehog-driven medulloblastoma. - Gregory E Hannigan
- Folic acid promotes tumour growth and STAT3 activation - Mariann Fagernaes Hansen*
- Mitochondrial Mutations and Metabolic Profiling of Pancreatic Cancer - Rae-Anne Hardie
- Combined targeted expression of the Pik3caH1047R and Apc mutations in the gastrointestinal tract causes invasive adenocarcinomas - Lauren M Hare
- APPLICATION OF IMAGING TECHNOLOGIES IN THE PRECLINICAL DEVELOPMENT OF NOVEL ONCOLOGY AGENTS - Athena Hatzimihalis
- Tumour manifestation is dictated by PML in a gender-specific manner in a mutant p53 cancer model - Sue Haupt
- Yeast techniques for modelling drugs targeting Bcl-2 and caspase family members - Christine J Hawkins
- E2F7 regulates sensitivity to the cytotoxic actions of anthracyclines in squamous cell carcinoma - Mehlika Hazar Rethinam
- Association of ABCA1 cholesterol transporter with poor outcome and aggressive phenotype in serous ovarian cancer. - Michelle Henderson
- Mutation of Foxo binding elements in the bim promoter does not abrogate Bim dependent killing - Marco J Herold
- Differential glycosylation of circulating proteins as diagnostic biomarkers for Barrett’s oesophagus and oesophageal adenocarcinoma - Michelle M Hill
- Regulation of colorectal tumor-initiating cells by the tight junction protein claudin-2. - Fred Hollande
- Cancer metastasis via the blood circulation promoted by novel proteolytic mechanisms - John D Hooper
- Connective tissue growth factor is increased in pre-B acute lymphoblastic leukaemia and mediates leukaemia - stromal cell interactions - Meegan Howlett
- Improving patient immune responses to monoclonal antibody therapies in epithelial cancer through changes in cellular trafficking and signaling pathways. - Lingbo Hu
- Improving patient immune responses to monoclonal antibody therapies in epithelial cancer through changes in cellular trafficking - Lingbo Hu
- TSP-1 expression in melanoma correlates with EMT and increased invasiveness - Christopher Hudson
- HIGH-RESOLUTION MOLECULAR PROFILING OF PRE-INVASIVE EPITHELIAL OVARIAN TUMOURS - Sally M Hunter
- Defining the Role of E3 Ubiquitin Ligase UBR5 in Cancer Through Substrate Identification - Mary Iconomou
- PTRF/cavin-1 modulates exosome content and function - Kerry L Inder
- Harnessing the tumour adaptive response to hypoxia to identify novel combinations of the vascular disrupting agent BNC105 with targeted therapeutics. - Daniel J Inglis
- Interleukin-3 signalling responses in myeloid cells - Anissa Jabbour
- The homeobox transcription factor Hhex regulates haematopoietic stem cell cycling and emergency haematopoiesis. - Jacob T Jackson
- A crucial role for the homeobox transcription factor Hhex in lymphogenesis. - Jacob T Jackson
- Investigating the effects of lymphoma mutations enhancing NFκB signalling - Yogesh Jeelall
- Normal breast epithelial subpopulations exhibit different responses to radiation induced DNA damage - Rebecca L Johnston
- Potential roles for thrombopoietin and platelets in lymphoma - Emma C Josefsson
- A critical role for ID4 in mammary stem cells and triple negative breast cancer - Simon Junankar
- Association of Myc oncogene family expression with patient outcome in ovarian and colorectal carcinomas - MoonSun Jung
- The partially-assembled GM-CSF receptor hexameric complex mediates cell survival - Winnie LT Kan
- Characterization of molecular features of MYC dependence and identification of a synthetic lethal interaction between MYC and CDK1 in human breast cancer cells - Jian Kang
- B-CELL ACTIVATING FACTOR (BAFF) PROMOTES LYMPHOMAS BY UPREGULATING TELOMERASE ACTIVITY IN B LYMPHOCYTES - Indzi Katik
- Inhibitors of Mitochondrial Apoptotic Pathway in Parapox virus - Livleen Kaur
- Functional interactions between p53 and anti-apoptotic Mcl-1 in sustaining the survival and growth of Myc-driven lymphoma. - Gemma L Kelly
- Breast Cancer in Pakistan, A review of current Situation. - Ammara Khalid
- Runx oncoproteins regulate cell fate decisions leading to senescence or survival. - Anna Kilbey
- Combined targeting of JAK2 and Bcl-2/Bcl-xL as a novel treatment strategy in JAK2-driven B-cell precursor Acute Lymphoblastic Leukemia (BCP-ALL) - Sang Kyu Kim
- Effects of Novel HDAC Inhibitors on the Proliferation, Colony Formation and Radiosensitivity of Brain Metastatic Breast Cancer Cells - Soo Kim
- Implications of Fc-engineering to a humanised anti-Ley antibody on Fc gamma receptor binding - Dylan T King
- Identification of Caspase-2 Specificity and Substrates - Tanja Kitevska
- The effect of netrin-1 on colorectal cancer cells and its malignant properties - Suhyoun Ko
- DISCOVERY OF NOVEL TELOMERASE INHIBITORS AND BINDING MODE PREDICTION - Manju Latha Krishna Moorthy
- Thrombospondin 4 is upregulated in breast cancer-associated stroma - Jamie R Kutasovic
- A High Throughput Screening Platform for the Identification of Small Molecule Inhibitors of the Ubiquitin E3 Ligase E6AP - Kurt Lackovic
- IAPs limit RIPK1-induced TNF biosynthesis - Najoua Lalaoui
- Chronic stress enhances progression of acute lymphoblastic leukemia through beta-adrenergic signaling - Donald M Lamkin
- Mixl1 expression in human leukemias and lymphomas - Katherine K Lange
- Understanding the roles of exosomes during epithelial-mesenchymal transition - Anh VP. Le
- Bcor loss-of-function mutations cooperate with Myc to drive lymphomagenesis in Eμ-Myc lymphoma. - Marcus Lefebure
- Discovery, Structure-Guided Design and Biological Validation of the First Potent and Selective Inhibitor of the Pro-Survival BCL-2 Family Member BCL-XL - Guillaume Lessene
- Receptor Tyrosine Kinases differ in their ability to confer resistance to Vemurafenib (PLX4032) treatment in BRAFV600E melanoma. - Frederic Li
- Targeting of Hedgehog pathway via pharmacologic inhibition of Gli induces apoptosis and autophagy in malignant mesothelioma cells - Chuan Bian Lim
- Sorting nexin 5 is a regulator of macropinocytosis in macrophages which also affects cell proliferation - Jet Phey Lim
- Structural biology of Scribble protein - Krystle Lim
- Identification of the determinants in CSK-Homologous Kinase (CHK) essential for its tumour suppressor function - Ya Chee Lim
- Medical utilization and cost of liver cancer under National Health Insurance in Taiwan: a population-based cross-sectional study - Yi-Hsien Lin
- Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor - Lisa M Lindqvist
- Re-engaging the Pax5-dependent transcriptional program in B progenitor acute lymphoblastic leukemia causes tumour differentiation and clearance - Grace J. Liu
- Small molecule inhibitors of ICMT as potential cancer therapeutics - Aaron M Lock
- Risk Factors Affecting the Survival Rate in Patients with SymptomaticPericardial Effusion Underwent Surgical Intervention - Mojtaba Lotfalian
- Conventional Forceps or Hot Biopsy: Comparative Study of Two Methods in Diagnosis of Endobronchial Lesions - Mojtaba Lotfalian
- Effects of Protein Arginine Methyltransferase 5 Knockdown or Inhibition on Tumour Cell Growth - Kym Lowes
- The characterisation of Adenomatous polyposis coli (APC) at the centrosome - Christina Lui
- Mechanistic basis for loss of cellular differentiation in colon cancer - Ian Y Luk
- DIFFERENTIAL EFFECTS OF STORE OPERATED CALCIUM ENTRY PROTEINS ON THE CALCIUM-MEDIATED TRANSCRIPTION FACTORS NFκB AND NFAT IN MDA-MB-231 BREAST CANCER CELLS - Nicole A Luk
Poster Session 2
7:30PM - 10:00PM
Friday, 15th February
Exhibition Hall
Sponsored by:
- Orphan Nuclear Receptor NUR77: A Potential Biomarker of Response to Epigenetic Treatment of Myelodysplasia - HongBin Liu
- Integrated genomics for prostate cancer - Geoff Macintyre
- Significant numbers of metabolically active irradiated tumour cells enter the circulation during a course of fractionated radiation therapy for non-small cell lung cancer: A novel finding with potential clinical significance - Michael P MacManus
- Proteomic analysis of 9 glioblastoma multiforme cell lines - Duthika Mallawaaratchy
- A systematic approach to identify novel cooperative tumour suppressor genes in Ras-driven tumourigenesis - Jan Manent
- The E3-ligase E6AP controls breast cancer invasion and motiliy by regulation of Rho-GTPases proteins - Mariam Mansour
- A synthetic-lethal screen for innate platinum resistance genes in lung adenocarcinoma - Kieren Marini
- Investigating the Inhibitory and Radiosensitising Properties of Dietary Polyphenols Resveratrol and [10]-Gingerol Against Metastatic Breast Tumour Cells - Ana Carolina Martin
- The relationship between Scribble structure, localisation and function - Claire A Martin
- Human epithelial ovarian cancer cell lines differentially express Sprouty proteins 1, 2 and 4 - Samar Masoumi Moghaddam
- Regulation of BH3-only proteins downstream of IL-3 and GM-CSF signalling - Dimitra Masouras
- Target gene identification of microRNAs associated with lymph node metastases in triple negative breast cancer - Andrea Mathe
- Reduced proliferation of murine B-cell lymphoma and acute myeloid leukaemia through RNAi-mediated loss of HDAC 3 occurs in a p53-dependent manner - Geoffrey Matthews
- TEMs (Tie2 Expressing Monocytes): Novel targets and effectors of anti-cancer therapies - Roberta Mazzieri
- Loss of the Tumor Suppressor Gene HIC1 Promotes Oncogenic Transformation in Mouse Embryonic Fibroblasts - Lisa McKenzie
- DNA Adduct-Forming Derivatives of the Anticancer Agents Mitoxantrone and Pixantrone - Jelena Medan
- Role of 2-morpholine substituted-1,3-benzoaxine family of compounds as chemo-sensitising agents, independent of DNA-PK - Terri Meehan-Andrews
- Phosphotyrosine profiling to define new therapeutic targets in infant MLL - Agnes Mendomo
- Cis-regulation of non-codings RNAs within the HOXC locus in breast cancer - Michael Milevskiy
- Role of APC in Mitochondrial Transport - Kate Mills
- Therapeutic and Research Potential of Stem cells - Stephen Minger
- Leptin increases the metastatic potential of breast cancer cells. - Ameet K. Mishra
- Plasma vitronectin predicts response to fluoropyrimidine-oxaliplatin chemotherapy in metastatic colorectal cancer - Mark P Molloy
- Cavin-1 alters oncogenic effects of caveolin-1 microdomains in prostate cancer - Hyeongsun Moon
- mRNA expression analysis of p53 isoforms in breast cancer - Brianna Morten
- Different protocols for Cryobiopsy versus Forceps Biopsy in Diagnosis of Patients with Endobronchial Tumors - amirhossein mozafarykhamseh
- Evaluation of anti-inflammatory kinase inhibitors for glioblastoma therapy - Lenka Munoz
- Identification and filtering of noisy probes for the Infinium HumanMethylation450 array - Haroon Naeem
- A Myc transcriptional program that is independent of EMT drives a poor prognosis tumour- propagating phenotype in HER2+ breast cancer - Radhika Nair
- Loss of ATRX or DAXX facilitates cellular immortalisation via the Alternative Lengthening of Telomeres pathway - Christine E Napier
- Functional characterization of microRNA isoforms with differential 3’ends - Corine T Neilsen
- The mutant p53 secretome drives invasion - Paul M Neilsen
- Elucidating the mechanisms of gene inactivation in a murine p53 shRNA-based Osteosarcoma model - Alvin JM Ng
- New roles for Interleukin-22 in the promotion of inflammation-associated gastric cancer. - Paul Nguyen
- L1 Retrotransposition and Somatic Genomic Instability in High-Grade Serous Ovarian Cancer - Thu H M Nguyen
- Exploiting the receptor uPARAP/Endo180 for targeted delivery of anti-cancer drugs to sarcomas and glioblastomas - Christoffer Nielsen
- Sex steroid receptor signalling and immune function - Rebecca Nightingale
- High expression of the telomerase-RNA binding protein dyskerin contributes to the proliferation and survival of neuroblastoma cells and is predictive of poor patient outcome - Rosemary O'Brien
- Hck Drives Tumour Associated Macrophage Transcriptional Profiles in Myeloid Cells Promoting Pulmonary Inflammation and Cancer. - Robert JJ O'Donoghue
- Kinetic modelling and the intrinsic apoptosis pathway - Martin O'Hely
- Jersey regulates mammary development and plays a key role in human breast carcinogenesis. - Samantha R Oakes
- Epigenomes of mouse mammary epithelial subsets - Bhupinder Pal
- Understanding Oncogenic PI3K in Colorectal Cancer - Michelle Palmieri
- Phosphoproteomics of cellular response to Vemurafenib reveals reprogramming by oncogenic B-RAF protein in Thyroid Cancer - Rob Parker
- A Bifunctional Fluorescent Assay for the Assessment of Cytotoxicity and Proliferation - Rachael Parry
- Molecular Changes Associated with Transformation of Liver Progenitor Cells - Adam Passman
- A telomere protective function of hTERT that is independent of catalytic activity. - Omesha Perera
- Therapeutic Approach to Target Mesothelioma Cancer Cells Using the Wnt Antagonist sFRP4: Metabolic State Of Cancer Cells - Vanathi Perumal
- A bioinformatic pipeline for the analysis of miRNAs in the PMC42 and MDA-MB-468 model systems of human breast cancer. - Gayle K Philip
- Identification and functional characterisation of miRNAs in breast development and malignancy - Yuwei Phua
- Variant repeats are interspersed throughout the telomeres of ALT cells, resulting in altered telomeric architecture - Hilda A Pickett
- A Single Transcriptional Program Underpins Patient Survival in Pancreatic Cancer - Mark Pinese
- An in vitro assay to screen novel potential driver genes of pancreatic carcinogenesis - Andreia V. Pinho
- Understanding Cancer Cell Populations in Breast Cancer – A Functional Genomics Approach - Cletus A Pinto
- Targeting a Novel MicroRNA Angiogenesis Pathway as a Next Generation Cancer Therapy - Prue N Plummer
- Haematopoietic Cell Kinase Promotes the Development and Progression of Colorectal Cancer in Mice. - Ashleigh Poh
- SOX11 as a potential target of FUS-DDIT3 in Myxoid Liposarcoma - Sophie Popkiss
- A DISINTEGRIN AND METALLOPROTEINASE ADAM-9 REGULATES THE METASTATIC PROPERTIES OF BREAST TUMOUR CELLS - Normand Pouliot
- Investigating modes of action for Pixantrone cytotoxicity and lack of cardiotoxicity - Paul P Pumuye
- Cytokines as key targets in cancer related inflammation - Tracy Putoczki
- A Novel Inhibitor of Ribosomal RNA Gene Transcription Identifies both p53-Dependent and p53-Independent Checkpoint Responses to Perturbation of Pol I Transcription - Jaclyn Quin
- Genomic analysis of human brain metastases: an integrative approach - Michael C J Quinn†
- RADIOSENSITIZING EFFECT OF BENZ 1, 3-OXAZINES AS NOVEL DNA-PK INHIBITORS IN THE TREATMENT OF CANCER - Suraj Radhamani
- Deconstructing the invasive machinery of cancer cells. - Troy J Ralph
- An siRNA screen to identify novel regulators of the cell cycle G2/M transition. - Max V. Ranall
- The anti-angiogenic properties of sulfated β-cyclodextrins in anti-cancer formulations incorporating 5-fluorouracil - Marie Ranson
- Stimulating the innate type-1 interferon pathway reduces breast cancer metastasis to bone - Jai Rautela
- Shifting doxorubicin activity from topoisomerase2 poison to adduct formation reduces cardiotoxicity while maintaining anticancer efficacy - David M Rayner
- Can cell death drive TNF dependent skin inflammation? - James Rickard
- PRIOR TO THE ONSET OF ADVANCED DISEASE, CANCER REPOPULATING CELLS IN LOCALISED PROSTATE TUMOURS ARE CASTRATE-RESISTANT AND STEM-LIKE. - Gail Risbridger
- CAPTIV: The Cancer of Prostate Translational Research in Victoria Collaboration - Gail P Risbridger
- Identification of new BIM regulators using over-expression and knockdown libraries - Leona Rohrbeck
- Sirtuin 1 is a novel regulator of pancreatic carcinogenesis - Ilse Rooman
- Combination therapy with raloxifene and a novel curcumin analog for the treatment of hormone refractory prostate cancer: in vitro mechanisms for synergistic cytotoxicity - Rhonda J Rosengren
- Next-Generation Sequence Analysis of Cancer Xenografts - Fernando Rossello
- Genomic profiling of primary mucinous ovarian carcinomas - Georgie L Ryland
- Differentiation Therapy for t(8;21) Acute Myeloid Leukemia - Jessica Salmon
- A novel therapeutic target in high-grade serous ovarian cancer: Connective Tissue Growth Factor (CTGF) - Goli Samimi
- Bioenergetic modulation sensitises acute lymphoblastic leukaemia to glucocorticoids - Amy L Samuels
- Identification of microRNAs that function downstream of Brca1 - Gurveen Sandhu
- Chemokine signalling in breast cancer angiogenesis - Michael J Sax
- Sex steroid receptor signalling in Flu specific T cells. - Manvendra Saxena
- Formation of an immunosuppressive pre-metastatic niche in breast cancer triggered by hypoxic tumour-derived factors - Jaclyn Sceneay
- Investigating DNA methylation in paediatric central nervous system tumours - Alexandra Sexton-Oates
- Histone deacetylase 2 promotes N-Myc oncogenesis by repressing the transcription of p53 induced nuclear protein 1 - Jeyran Shahabzi
- Defining Ubiquitin Ligase Function in Breast Cancer - Robert Shearer
- Mutagenic potential of direct apoptosis inducers - Tanmay Shekhar
- Targeting MUC13 to sensitise colorectal cancer cells to apoptosis - Yong H Sheng
- Evaluation of the CDK4 Inhibitor PD-0332991 in Melanoma and Identification of Genomic Predictors of Sensitivity - Karen E Sheppard
- Hhex regulates therapeutic resistance of Lmo2-induced pre-Cancerous Stem Cells. - Benjamin J Shields
- RNA aptamers targeting CD133 as a novel targeted therapeutic for the treatment of cancer - Sarah L Shigdar
- Regulation of the matricellular proteins CCN1/Cyr61 and CCN2/CTGF by vitronectin induces cancer cell survival - Ali Shokoohmand
- Screen small, diverse compound subsets from the Queensland Compound Library “Open” collection - Moana M Simpson
- A novel role for pericytes as ‘cancer associated fibroblasts’ in ovarian cancer progression and metastasis - Devbarna Sinha
- A ROLE FOR THE FREE BETA SUBUNIT OF HUMAN CHORIONIC GONADOTROPIN IN SENSITIVITY OF EPITHELIAL OVARIAN CANCER CELLS TO PLATINUM-BASED CHEMOTHERAPEUTICS - Snega S Sinnappan
- DNA Damage Response in Peripheral Blood Lymphocytes and Out-of-Field Hair Follicles During Radiotherapy of Patients with Non-Small Cell Lung Cancer: A Prospective Clinical Trial - Shankar Siva
- GENOME-WIDE GAIN-OF-FUNCTION SCREEN FOR GENES THAT INDUCE EPITHELIAL TO MESENCHYMAL TRANSITION IN BREAST CANCER - Dubravka Skalamera
- Generation of a Genome Scale Lentiviral Vector Library for EF1α Promoter- Driven Expression of Human ORFs and Identification of Human Genes Affecting Viral Titer - Dubravka Škalamera
- Neural regulation of metastasis: New avenues for therapeutic intervention - Erica K Sloan
- Inactivation of USP44, a regulator of global H2BK120ub levels, is an early event in the formation of colorectal cancer - Mathew A. Sloane
- Tumour Suppression via Re-equilibration of Cell Polarity Networks. - Lorey Smith
- Discovery of microRNAs associated with Breast Cancer Epithelial Mesenchymal Plasticity using Bioinformatics and Next Generation Sequencing - Eliza Soo
- Flavopiridol – a novel therapeutic option for NUT midline carcinoma - Anja Stirnweiss
- BCL-2 expression is silenced by DNA hypermethylation in human breast cancer, providing a potential biomarker of sensitivity to mitotic inhibition. - Andrew Stone
- The loss of Cdkn2a locus is a critical event in the transformation of liver progenitor cells - Robyn Strauss
- Deletion of Myc limits the growth of Stat3-driven gastric tumours - Emma C Stuart
- Functional analysis of TERT locus polymorphisms which are associated with risk of breast and ovarian cancer - Michael D Stutz
- Histone deacetylase 5 forms a transcriptional repressor complex with N-Myc and blocks tumour cell differentiation - Yuting Sun
- CHARACTERIZATION OF NOVEL DNA-PK INHIBITOR FROM ISOFORM SPECIFIC PI3K AS AN ANTI-CANCER DRUG - Rejitha Suraj
- High-throughput identification and characterization of novel enhancer molecule for hydroxamate-based histone deacetylase inhibitors - Aldwin Suryo Rahmanto
- Detection of autophagy - AlphaLISA assays - Margareta Sutija
- Metastatic tumours promote monocyte mobilisation - Agnieszka Swierczak
- Role of the unfolded protein response in melanoma progression and metastasis - Erin K Sykes
- Loss of Tumor Suppressor Hic1 Accelerates the Progression of Lung Adenocarcinoma Induced by Oncogenic KRas - Anette Szczepny
- Molecular analysis of circulating (CTC) and disseminated tumour cells (DTC) in human breast cancer xenograft models. - Anthony Tachtsidis
- The atypical kinase SgK223 is a novel mediator of cell invasion in pancreatic cancer - Carole M Tactacan
- Frequent alterations in mTOR signaling in human ovarian serous carcinomas - Pradeep Tanwar
- Assessing the regulatory function of small RNAs - Daniel W Thomson
- Multiple mechanisms of resistance to targeted inhibitors in c-Kit mutant melanoma - Jason Todd
- Evaluation of the efficacy of bromodomain inhibitors for the treatment of colorectal cancer - Lars Tögel
- Differential Effects of Oxytocin on Androgen Independent Prostate Cancer Cells - Nicole C Tom
- A FUNCTIONAL IN VIVO shRNA SCREEN FOR BREAST CANCER METASTASIS SUPRESSOR GENES - Rebeka Tomasin
- Identification and validation of two novel metastatic markers in Osteosarcoma. - Eleni Topkas
- Designing targeted therapies for High-Grade Serous Ovarian Cancer (HG-SOC) utilising a novel xenograft cohort stratified according to molecular defects - Monique D Topp
- Absence of senescence traits in human melanocytic nevi - Sieu L Tran
- Histone deacetylase and proteasome inhibitors induce overlapping transcriptional responses and synergistically induce apoptosis in tumour cells. - Janson JT Tse
- The antimicrobial peptide LL-37 inhibits migration of prostate cancer cells - Yan Tu
- Complete loss of the p53 effectors p21, Puma and Noxa does not predispose mice to spontaneous tumor development - Liz J Valente
- Understanding the role of tumour suppressor TRIM35 in TGF-ß signaling - Joanne H. van Vuuren
- A new Bcl-2-specific BH3-mimetic has in vivo efficacy without provoking thrombocytopenia - Cassandra Vandenberg
- Investigating the role of exosomes in promoting melanoma metastasis. - Laura J Vella
- Combined targeting of JAK2 and Bcl-2/Bcl-xL as a novel, potentially curative treatment for haematological malignancies expressing mutant JAK2 - Michaela Waibel
- High-grade mucinous ovarian cancer: from where does it originate and how should it be treated? - Matthew Wakefield
- MYD88 mutation in B-cells - effects on NFkB activity, B-cell survival and proliferation - James Q Wang
- STAT3 inhibitor S3I-201 suppresses human osteosarcoma cell growth - Xiaochun Wang
- Anti-cancer efficacy of histone deacetylase inhibitors mediated by immune system - Alison C West
- Identifying predictors of sensitivity to PF-00477736 in melanoma - Britanto Wicaksono
- Dynamic expression of EMT-related mRNA alternative splicing variants in human mammary carcinoma - Edwin Widodo
- Not so minor after all. Emerging roles for “minor class” splicing in cancer. - Benjamin B Williams
- In Vivo biomarker expression patterns are preserved in 3D cultures of Prostate Cancer - Louisa CE Windus
- Defining the gene regulatory network controlled by the tumour suppressor Ikaros in thymocytes and T cell leukemia using dynamic in vivo RNAi - Matthew Witkowski
- Understanding the mechanism of erythroid enucleation: a chemical genetics approach - Christina B Woelwer
- E6-Associated Protein (E6AP) regulates the INK4/ARF locus and oncogene-induced senescence - Kamil Wolyniec
- Achieving increased chemotherapeutic efficacy in breast cancer by loss of Siah2 - Christina S.F. Wong
- Increased Interferon Response Gene Expression During Megakaryocyte Ontogeny: Implications for the Spontaneous Resolution of Down Syndrome Transient Myeloproliferative Disorder - Andrew J. Woo
- Novel small molecules that target the dimer interface of 14-3-3 proteins as a basis for possible anti-cancer therapeutics. - Joanna Woodcock
- Processing and presentation of NY-ESO-1 epitopes by melanoma cells. - Katherine Woods
- Isolation and characterization of prostate cancer initiating cells based on aldehyde dehydrogenase activity - Jinhan (Angela) Xie
- mTOR Inhibition in Biliary Tract Cancer - Yvonne Yeung
- Fibroblast Growth Factor Receptor 1 Gene Amplification in Oral Tongue Squamous Cell Carcinoma - Frequency and Associations with Clinical Features and Patient Outcome - Richard J Young
- Transcription Factor ATF3 Suppresses Bladder Cancer Metastases by Regulating Gelsolin-Mediated Actin Cytoskeleton Remodeling - Liang Yu
- Characterization of the novel broad-spectrum kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based kinome profiling - Luxi Zhang
- Human Breast Cancer Cell Lines and micro-RNAs in the Quail Embryo – A model for short term in vivo responses. - Tania Zheng
- Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue (FFPET) using MBDCap-Seq identifies novel epigenetic diagnostic biomarker loci in breast cancer - Elena Zotenko*
- The biological function of parallel telomeric G-quadruplexes and their interaction with the cancer associated enzyme telomerase - Katherine G Zyner
- Triazolophanes as a novel class of G-quadruplex binding agents - Lucy Ping
- The inflammation-resolving trihydroxy-docosahexaenoic acid derivative, resolvin D2 supports MCF-7 cell proliferation via activation of estrogen receptor - Nuha Alzaubai
- The prognostic significance of ALDEHYDE DEHYDROGENASE 1 (ALDH1) and CD133 expression in early-stage non-small cell lung cancer. - Alamgeer Muhammad